Magic mushrooms have been known as mushrooms that can cause high levels of hallucinations. However, a recent study found that magic mushrooms can be used to treat depression. This study is the first of two phases of testing for psilocybin. The second trial will involve more participants as many as 200 patients with depression throughout Europe and North America. The study also plans to look at the drug’s response to several mental health conditions such as anxiety, addiction, and obsessive-compulsive disorder (OCD). Previously, the United States Food and Drug Administration (FDA) has approved the use of psilocybin and dose rounding chemotherapy to treat several types of depression.
Research from King’s College London found the active ingredient psilocybin found in mushrooms can be used to treat depression. This drug is new hope for millions of people with depression in the world. The study was conducted by giving psilocybin to 89 volunteers. This study then compared the effects of administering 10 milligrams and 25 milligrams of psilocybin, and a placebo. As a result, the participants who used psilocybin experienced changes in sensory perception and experienced positive moods. These results are similar to the effects of psychedelic drugs on people with depression. Researchers also found no serious side effects on cognitive and emotional function in people taking psilocybin. The results of this study are clinically convincing and support the further development of psilocybin as a treatment for patients with mental health problems that have not improved with conventional therapy, such as treatment-resistant depression.
Based on data from the World Health Organization (WHO), currently, more than 264 million people worldwide are affected by depression. The most common treatment is to use antidepressants that can improve mood. However, these types of antidepressants do not work for everyone and generally must be taken in the long term. In contrast, psychedelic drugs such as psilocybin can rapidly alter brain function and treat depressed patients with multiple doses in combination with therapy.